Nicholas A. Vitanza et al. [53] created three kinds of HER2 antigen-specific CAR-T cells with different lengths of spacers—short, medium, and long—and injected them into the glioma transplanted in situ in mice. Here, ERBB2 is linked to central nervous system cancer.